CNO-PA — CNO Financial Group, Inc. 5.125

CNO Financial Group Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Operating Earnings per Share (EPS): $1.26, up 45% year-over-year.
• Sales Growth: 16th consecutive quarter of sales growth; total new annualized premiums increased by 7%.
• Book Value per Share: $39.92, up 5%.
• Return on Equity (ROE): 14.1% on a trailing 12-month basis.
• Expense Ratio: 18.4%, with expectations of normalization in the latter half of the year.
• Shareholder Returns: $77 million returned to shareholders, including $60 million in share repurchases.

2. Strategic Updates and Business Highlights

• Sales Performance: Strong across both Consumer and Worksite divisions. Notable records in Medicare Supplement (NAP up 52%) and annuities (collected premiums of $536 million, up 3%).
• Agent Growth: Producing agent count increased by 3%, marking the 14th consecutive quarter of growth.
• Product Diversification: Continued focus on a diversified product portfolio addressing health, wealth, and income protection needs, with a strong emphasis on middle-income consumers.
• Investment Strategy: Net investment income increased by 8% year-over-year, with a new money rate of 6.16%.

3. Forward Guidance and Outlook

• Operating EPS Guidance: Increased to a range of $4.60 to $4.80 for the full year, reflecting an 8% increase at the midpoint.
• Expense Ratio Guidance: Narrowed to 18.8% to 19.0%.
• Effective Tax Rate: Lowered to approximately 21.5%.
• Long-term ROE Goal: Expected to exceed 12% by year-end 2027, with intentions to establish new targets in February 2027.

4. Bad News, Challenges, or Points of Concern

• Life Insurance Sales: Life NAP decreased by 9% due to lower direct-to-consumer sales, with expectations of variability as the company transitions marketing strategies.
• Consumer NAP Deceleration: Concerns about potential deceleration in consumer NAP growth, particularly as comparisons become more challenging in upcoming quarters.
• Market Competition: Increased competition in the annuity market, though CNO's captive distribution model provides some insulation from broader market pressures.

5. Notable Q&A Insights

• Long Term Care Margins: Margins have improved, with claims experience trending better than expected; further analysis will be conducted in the upcoming quarterly review.
• Worksite Business Growth: Continued growth attributed to geographic expansion and improved sales force maturity, with no major strategic changes.
• Medicare Supplement Margins: Recent favorable claims reserve development of approximately $4 million noted, but future margins may need adjustment based on this one-time benefit.
• Capital Deployment: No changes in capital deployment strategy; focus remains on reinvestment in business and shareholder returns, with ongoing evaluation of opportunities in Bermuda.

Overall, CNO Financial Group reported a strong quarter with significant growth in operating earnings and sales, while also addressing potential challenges in specific product lines and market competition. The company remains optimistic about its long-term growth trajectory and strategic initiatives.